Skip to main content
Clinical Trials/NCT03823963
NCT03823963
Unknown
Phase 4

A Monocentric, Comparative and Randomized Study on Pressure Ulcers Prevention With Mepilex® Border Sacrum Dressing in Scheduled Cardiovascular Surgery

University Hospital, Clermont-Ferrand1 site in 1 country478 target enrollmentDecember 10, 2018

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Pressure Ulcers
Sponsor
University Hospital, Clermont-Ferrand
Enrollment
478
Locations
1
Primary Endpoint
Pressure ulcer incidence
Last Updated
7 years ago

Overview

Brief Summary

The study is a randomised controlled trial of patients admitted for a scheduled cardiac surgery at the Clermont-Ferrand hospital.

Patients meeting the study inclusion criteria will be allocated to either the control group that will receive pressure ulcer prevention standard care or the intervention group that will receive pressure ulcer prevention standard care plus have a Mepilex® Border dressing applied to their sacrum.

Detailed Description

The main objective of this research is to evaluate the impact of Mepilex Border® dressing applied in addition to standard pressure ulcer prevention protocol, in a French hospital setting, in at-risk patients in a cardiovascular surgery unit with full hospitalisation including block operation and ICU. Hypothesis: Patients treated with Mepilex® Border dressings will have a lower incidence rate of sacral pressure ulcer development than patients receiving standard care.

Registry
clinicaltrials.gov
Start Date
December 10, 2018
End Date
January 31, 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject over 18 years of age,
  • Subject programmed to benefit from cardiac surgery with sternotomy,
  • Subject capable and willing to comply with the protocol and willing to give his written consent,
  • Subject affiliated to a social security system

Exclusion Criteria

  • Subject with a skin lesion in the sacral area upon admission,
  • Subject admitted for emergency cardiovascular surgery (unscheduled subject),
  • Subject admitted for heart transplant surgery,
  • Subject participating in another clinical study or in a period of exclusion from a study previous,
  • Subject with a linguistic or psychological disability to sign informed consent,
  • Subject refusing to give written consent,
  • Subject deprived of liberty by administrative or judicial decision, under guardianship or curatorship.

Outcomes

Primary Outcomes

Pressure ulcer incidence

Time Frame: 0-20 days

Incidence of sacral pressure ulcers acquired during patients' hospital stay

Study Sites (1)

Loading locations...

Similar Trials